Join
Live feed
·
INSIDERFilingvia Quantisnow
GT Biopharma Inc. logo

SEC Form 4: Breen Michael Martin was granted 278,058 shares, increasing direct ownership by 85% to 606,218 units

ByQuantisnow·Wall Street's wire, on your screen.
GTBP· GT Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GTBP (GT Biopharma Inc.) and more on Quantisnow.